197 related articles for article (PubMed ID: 24445408)
1. [Importance of nuclear medicine diagnostics in CUP syndrome].
Winter MC; Haberkorn U; Kratochwil C
Radiologe; 2014 Feb; 54(2):134-9. PubMed ID: 24445408
[TBL] [Abstract][Full Text] [Related]
2. Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary.
Pawaskar AS; Basu S
PET Clin; 2015 Jul; 10(3):297-310. PubMed ID: 26099668
[TBL] [Abstract][Full Text] [Related]
3. A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site.
Møller AK; Loft A; Berthelsen AK; Pedersen KD; Graff J; Christensen CB; Costa JC; Skovgaard LT; Perell K; Petersen BL; Daugaard G
Oncologist; 2012; 17(9):1146-54. PubMed ID: 22711751
[TBL] [Abstract][Full Text] [Related]
4. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
Ruhlmann V; Ruhlmann M; Bellendorf A; Grueneisen J; Sawicki LM; Grafe H; Forsting M; Bockisch A; Umutlu L
Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
[TBL] [Abstract][Full Text] [Related]
5. Utility of F-18 fluorodeoxyglucose posıtron emıssıon tomography/computed ın carcınoma of unknown primary.
Elboga U; Kervancioğlu S; Sahin E; Basibuyuk M; Celen YZ; Aktolun C
Int J Clin Exp Pathol; 2014; 7(12):8941-6. PubMed ID: 25674269
[TBL] [Abstract][Full Text] [Related]
6. [Radiological diagnostics in CUP syndrome].
Kazmierczak PM; Nikolaou K; Rominger A; Graser A; Reiser MF; Cyran CC
Radiologe; 2014 Feb; 54(2):117-23. PubMed ID: 24500247
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: a literature review.
Moller AK; Loft A; Berthelsen AK; Damgaard Pedersen K; Graff J; Christensen CB; Perell K; Petersen BL; Daugaard G
Oncologist; 2011; 16(4):445-51. PubMed ID: 21427201
[TBL] [Abstract][Full Text] [Related]
8. [Importance of PET/CT in lymphoma diagnostics].
Afshar-Oromieh A; Kratochwil C; Haberkorn U; Giesel FL
Radiologe; 2012 Apr; 52(4):338-46. PubMed ID: 22526115
[TBL] [Abstract][Full Text] [Related]
9. [Positron emission tomography in CUP syndrome].
Röhrich M
Radiologie (Heidelb); 2023 May; 63(5):354-357. PubMed ID: 37079059
[TBL] [Abstract][Full Text] [Related]
10. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
Salem SS; Shahin MA
Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
[TBL] [Abstract][Full Text] [Related]
12. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
Tamam MO; Mulazimoglu M; Guveli TK; Tamam C; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(15):2120-30. PubMed ID: 23280029
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
[TBL] [Abstract][Full Text] [Related]
14. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
15. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
[TBL] [Abstract][Full Text] [Related]
16. Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis.
Kwee TC; Kwee RM
Eur Radiol; 2009 Mar; 19(3):731-44. PubMed ID: 18925401
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT in carcinoma of unknown primary.
Kwee TC; Basu S; Cheng G; Alavi A
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):635-44. PubMed ID: 19882152
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of whole-body F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with carcinoma of unknown primary.
Wang G; Wu Y; Zhang W; Li J; Wu P; Xie C
J Med Imaging Radiat Oncol; 2013 Feb; 57(1):65-71. PubMed ID: 23374557
[TBL] [Abstract][Full Text] [Related]
19. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
[TBL] [Abstract][Full Text] [Related]
20. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
